CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Compartment-specific GLUT1 patterns in colorectal liver metastases: invasive-margin GLUT1 associates with outcome in solitary disease.
Compartment-specific GLUT1 patterns in colorectal liver metastases: invasive-margin GLUT1 associates with outcome in solitary disease.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
GLUT1 在 CRLM 中表现出区室和背景依赖性关联。肿瘤核心 GLUT1 与增殖活性相关,而浸润边缘 GLUT1 在孤立性转移中与良好结局相关。免疫荧光和功能数据提供了产生假设的背景,值得通过定量空间免疫分析和独立队列进行验证。
结直肠癌肝转移(CRLM)是癌症相关死亡的主要原因。葡萄糖转运蛋白1(GLUT1)是恶性肿瘤细胞和免疫细胞糖酵解代谢的关键介质;然而,CRLM中区室特异性GLUT1模式的预后相关性仍未明确。我们假设肿瘤-肝脏界面的空间GLUT1表达可能反映具有临床相关性的微环境生物学。
我们回顾性分析了 192 例因 CRLM 接受根治性切除术的患者的数据(75 例单发;117 例多发)。通过免疫组织化学评估肿瘤组织 (Tu) 和浸润边缘 (Im) 中的 GLUT1 表达,并使用 Cox 回归与总生存率相关。对 CD8 和 GLUT1 进行双重免疫荧光,以在浸润边缘进行定性可视化。在探索性子集中 (n = 5),对 GLUT1 与 GLUT1 CD8 TIL(肿瘤浸润淋巴细胞)进行流式细胞术和体外杀伤测定。
肿瘤GLUT1与Ki67相关(Spearman's = 0.31,p = 0.003),但在主队列中与总生存期无独立关联(多变量HR 1.183,95% CI 0.74-1.90;p = 0.485)。在主队列中,包膜存在仍与生存改善强烈相关(HR 0.35,95% CI 0.21-0.58;p < 0.001)。相反,在预设的孤立性队列中,高侵袭边缘GLUT1与生存改善独立相关(HR 0.379,95% CI 0.18-0.81;p = 0.012)。双重免疫荧光显示GLUT1信号与CD8细胞在浸润边缘的定性共定位。在探索性试验(n = 5)中,流式细胞术提示GLUT1富集于重新表达CD45RA的CD8终末分化效应记忆T细胞(TEMRA),且GLUT1 TIL组分显示出比GLUT1细胞更高的体外肿瘤细胞杀伤能力。
Colorectal liver metastases (CRLM) are a major cause of cancer-related deaths. Glucose transporter 1 (GLUT1) is a key mediator of glycolytic metabolism in malignant and immune cells; however, the prognostic relevance of compartment-specific GLUT1 patterns in CRLM remains undefined. We hypothesized that spatial GLUT1 expression at the tumor-liver interface may reflect clinically relevant microenvironmental biology.
We retrospectively analyzed data of 192 patients who underwent curative-intent resection for CRLM (75 solitary; 117 multiple). GLUT1 expression was assessed by immunohistochemistry in the tumor tissue (Tu) and infiltration margin (Im) and was correlated with overall survival using Cox regression. Double immunofluorescence for CD8 and GLUT1 was performed for qualitative visualization at the infiltration margin. In an exploratory subset (n = 5), flow cytometry and in vitro killing assays were conducted on GLUT1 versus GLUT1 CD8 tumor-infiltrating lymphocytes (TILs).
Tumoral GLUT1 correlated with Ki67 (Spearman's = 0.31, p = 0.003) but was not independently associated with overall survival in the main cohort (multivariable HR 1.183, 95% CI 0.74-1.90; p = 0.485). In the main cohort, capsule presence remained strongly associated with improved survival (HR 0.35, 95% CI 0.21-0.58; p < 0.001). In contrast, high invasive-margin GLUT1 was independently associated with improved survival in the predefined solitary cohort (HR 0.379, 95% CI 0.18-0.81; p = 0.012). Double immunofluorescence demonstrated the qualitative co-localization of the GLUT1 signal with CD8 cells at the infiltration margin. In exploratory assays (n = 5), flow cytometry suggested GLUT1 enrichment in CD8 terminally differentiated effector memory T cells re-expressing CD45RA (TEMRA), and GLUT1 TIL fractions showed higher in vitro tumor cell killing compared with GLUT1 cells.
GLUT1 shows compartment- and context-dependent associations in the CRLM. While tumor-core GLUT1 is linked to proliferative activity, invasive-margin GLUT1 is associated with favorable outcomes in solitary metastases. Immunofluorescence and functional data provide hypothesis-generating context and warrant validation with quantitative spatial immune profiling and independent cohorts.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。